Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Clinical Trial
Share your love
Infographic: landmark trials in neuro-ophthalmology – results of the REVERSE trial for unilateral gene therapy rAAV2/2-ND4 in leber hereditary optic neuropathy – Nature
Infographic: landmark trials in neuro-ophthalmology – results of the REVERSE trial for unilateral gene therapy rAAV2/2-ND4 in leber hereditary optic neuropathy Nature Source: Author: | Date: 2025-07-16 07:00:00 Source: Author: | Date: 2025-07-16 07:00:00
Infographic: Landmark trials in Neuro-Ophthalmology—results of the phase II Idiopathic Intracranial Hypertension Pressure Trial | Eye – Nature
Infographic: Landmark trials in Neuro-Ophthalmology—results of the phase II Idiopathic Intracranial Hypertension Pressure Trial | Eye Nature Source: Author: | Date: 2025-07-15 07:00:00 Source: Author: | Date: 2025-07-15 07:00:00
Infographic: landmark trials in neuro-ophthalmology—results of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) | Eye – Nature
Infographic: landmark trials in neuro-ophthalmology—results of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) | Eye Nature Source: Author: | Date: 2025-07-04 07:00:00 Source: Author: | Date: 2025-07-04 07:00:00
A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial – Frontiers
A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial Frontiers Source: Author: | Date: 2024-04-23 07:00:00 Source: Author: | Date: 2024-04-23 07:00:00
New Guidelines By The European Glaucoma Society I OBN
New theories about the causes, processes, and treatments of glaucoma are constantly being developed. The European Glaucoma Society’s mission is to advance the greatest level of health and the least amount of glaucoma-related visual impairment among glaucoma patients within an…
TearRestore’s New Dry Eye Products Are Available at Target
TearRestore has recently announced that their Thermal Mask and Eyelid Wipes will now be available for purchase both in Target stores across the United States and on Target’s online shopping platform, Target.com. According to TearRestore, their Thermal Mask and Eye…
ChatGPT Scores Nearly 50% on Ophthalmology Exam
ChatGPT, an artificial intelligence tool, was found to have a low accuracy rate, answering less than half of the questions from a commonly used study resource for physicians preparing for board certification in ophthalmology, according to a study led by…
Espansione Announces Lightwave II | OBN
Espansione Group announced today the second wave of its major research effort aimed at contributing to the prevention and management of dry AMD. Having announced the European study LightWave I at ESCRS 2022 in Milan, Espansione Group is today announcing…
Presbyopia Correcting Drops | OBN
The eye drops don’t treat the cause of presbyopia but help treat its symptoms. Instead of targeting the eyes’ lens, the drops make the eyes’ pupils smaller, creating a pinhole effect that increases the depth of focus. The eye drops…
How to Diagnose and Treat Thyroid Eye Disease
TED is an autoimmune disease in which the eye muscles and fatty tissue behind the eye become inflamed. This inflammation can push the eyes forward (“staring” or “bulging”) or cause the eyes and eyelids to become red and swollen. In some…